Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Irvine Scientific begins industrial cell culture media shipments in Japan

Irvine Scientific : 25 August, 2011  (Company News)
Irvine Scientific, a member of JX Holdings group, begins shipping the first products manufactured to customers from its Industrial Cell Culture media production facility in Tokyo, Japan.

The new facility, located in Saitama prefecture, has the capacity to manufacture animal component free cell culture media in volume requirements ranging from research uses to production of biopharmaceuticals and vaccines. The facility has been commissioned and validated as completely animal component free (ACF).

Irvine Scientific is a worldwide media provider that is regulated and adheres to both ISO and FDA regulations. The Irvine Scientific Tokyo facility is designed for maximum efficiency and to meet the highest quality cGMP standards.

The new site currently occupies 1,720 square metres of a facility designed to replicate the production and processes used at the company’s Santa Ana, California manufacturing facility. The Tokyo site has state-of-the-art formulation and packaging equipment, and utilizes continuous milling and blending equipment designed and built to Irvine Scientific specifications. The facility will further secure Irvine Scientific’s flexible customer-centric approach to media supply.

The Tokyo site has room to expand as needed to meet customer demands. This expanded capacity and system redundancy to the existing site in Santa Ana provides customers with the security and redundancy of supply that they require in the later product stages. The systems and location are ideally suited to serve Irvine Scientific's growing customer base in Japan and Asia.

The Tokyo and Santa Ana sites use identical equipment and processes along with consistent raw materials, which assure that the media produced in either location adheres to agreed upon customer expectations and regulatory quality system requirements. The Tokyo facility capacity doubles Irvine Scientific's current powder manufacturing capacity at Santa Ana, California, USA and will bring the total capacity at both sites to over 1.2 million Kg/year.

Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo